We are live on ! Find out more
BSHC

Breed's Hill Capital Portfolio holdings

AUM $208M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
+14.53%
1 Year Est. Return
+20.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$22.3M
Cap. Flow
-$534K
Cap. Flow %
-0.26%
Top 10 Hldgs %
55.35%
Holding
144
New
8
Increased
33
Reduced
43
Closed
4
Avg Time Held
4.3 quarters
Top 10 Avg Time Held
4.8 quarters
Top 20 Avg Time Held
5.4 quarters

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$419K
2
JBL icon
Jabil
JBL
+$227K
3
PANW icon
Palo Alto Networks
PANW
+$213K
4
TSM icon
TSMC
TSM
+$205K
5
PH icon
Parker-Hannifin
PH
+$205K

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.43%
2 Technology 20.5%
3 Healthcare 4.46%
4 Consumer Discretionary 4.3%
5 Financials 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INTU icon
51
Intuit
INTU
$82B
$652K 0.31%
828
-1
-0.1% -$677
2023 Q4
6 quarters
HD icon
52
Home Depot
HD
$291B
$649K 0.31%
1,771
+200
+13% +$72.4K
2024 Q4
2 quarters
BX icon
53
Blackstone
BX
$85.8B
$625K 0.3%
4,180
+29
+0.7% +$3.98K
2024 Q3
3 quarters
APD icon
54
Air Products & Chemicals
APD
$63.6B
$593K 0.29%
2,104
– –
2023 Q4
6 quarters
GEV icon
55
GE Vernova
GEV
$267B
$593K 0.29%
1,120
+21
+2% +$8.74K
2024 Q4
2 quarters
ZTS icon
56
Zoetis
ZTS
$31B
$574K 0.28%
3,683
– –
2023 Q4
6 quarters
NOW icon
57
ServiceNow
NOW
$147B
$558K 0.27%
2,715
+150
+6% +$28.3K
2024 Q4
2 quarters
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$129B
$558K 0.27%
1,253
+27
+2% +$12.4K
2024 Q4
2 quarters
IGV icon
59
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
$548K 0.26%
5,000
– –
2023 Q4
6 quarters
JNJ icon
60
Johnson & Johnson
JNJ
$633B
$539K 0.26%
3,526
-4
-0.1% -$615
2023 Q4
6 quarters
EMR icon
61
Emerson Electric
EMR
$90.9B
$535K 0.26%
4,009
– –
2023 Q4
6 quarters
IJH icon
62
iShares Core S&P Mid-Cap ETF
IJH
$123B
$530K 0.26%
8,550
– –
2023 Q4
6 quarters
BSX icon
63
Boston Scientific
BSX
$62.6B
$528K 0.25%
4,914
+1
+0% +$101
2024 Q1
5 quarters
SYK icon
64
Stryker
SYK
$108B
$523K 0.25%
1,321
-1
-0.1% -$374
2024 Q4
2 quarters
VEU icon
65
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
$520K 0.25%
7,729
-64
-0.8% -$4.05K
2025 Q1
1 quarter
TJX icon
66
TJX Companies
TJX
$155B
$517K 0.25%
4,189
– –
2024 Q2
4 quarters
TSLA icon
67
Tesla
TSLA
$1.5T
$507K 0.24%
1,595
-4
-0.3% -$1.21K
2024 Q4
2 quarters
ADP icon
68
Automatic Data Processing
ADP
$108B
$503K 0.24%
1,631
-128
-7% -$39.3K
2023 Q4
6 quarters
PG icon
69
Procter & Gamble
PG
$355B
$495K 0.24%
3,108
-57
-2% -$9.3K
2023 Q4
6 quarters
BAC icon
70
Bank of America
BAC
$380B
$481K 0.23%
10,156
+73
+0.7% +$3.07K
2023 Q4
6 quarters
XLF icon
71
State Street Financial Select Sector SPDR ETF
XLF
$51.2B
$477K 0.23%
9,100
– –
2023 Q4
6 quarters
ADBE icon
72
Adobe
ADBE
$92.9B
$466K 0.22%
1,204
+34
+3% +$13.1K
2024 Q4
2 quarters
ASML icon
73
ASML
ASML
$678B
$449K 0.22%
560
– –
2023 Q4
6 quarters
AMD icon
74
Advanced Micro Devices
AMD
$968B
$439K 0.21%
3,093
+589
+24% +$64.1K
2023 Q4
6 quarters
AXP icon
75
American Express
AXP
$211B
$438K 0.21%
1,373
– –
2023 Q4
6 quarters

Similar funds

Breed's Hill Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Breed's Hill Capital held 144 positions worth $208M, up 12% from $185M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Breed's Hill Capital's Q2 2025 filing shows 8 new, 33 increased, 43 reduced and 4 closed positions. Its largest new stake was Jabil: 1,400 shares worth $305K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474K.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, down from 60% a quarter earlier, followed by Technology and Healthcare.

  • Breed's Hill Capital's largest Q2 2025 buy was Jabil: 1,400 shares worth $305K.
  • Breed's Hill Capital added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $419K increase.
  • Breed's Hill Capital's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474K.
  • Breed's Hill Capital fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $390K.
  • Breed's Hill Capital's ten largest holdings make up 55% of its $208M portfolio in Q2 2025.
  • Breed's Hill Capital opened 8 new positions and closed 4 in Q2 2025.
  • Breed's Hill Capital's portfolio value rose 12% quarter-over-quarter to $208M.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.